H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 56 Citations 20,339 125 World Ranking 2117 National Ranking 75


What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Cancer

Immunology, Cell biology, T cell, Antigen and Immune system are his primary areas of study. His Cell biology study combines topics from a wide range of disciplines, such as Receptor, IL-2 receptor and CD80. Koji Tamada has included themes like Cytokine, Immune tolerance, Cancer immunotherapy, Molecular biology and Cytotoxic T cell in his T cell study.

Within one scientific family, Koji Tamada focuses on topics pertaining to Tumor necrosis factor alpha under Cancer immunotherapy, and may sometimes address concerns connected to Cancer research. His work in Antigen covers topics such as B7-H1 Antigen which are related to areas like Blockade. His Immune system research is multidisciplinary, incorporating elements of Interleukin 12 and Infiltration.

His most cited work include:

  • Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion (3453 citations)
  • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion (1957 citations)
  • Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity (829 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Cancer research, Immune system, T cell and Cytotoxic T cell. Koji Tamada focuses mostly in the field of Immunology, narrowing it down to matters related to Interleukin 12 and, in some cases, CD40. His Cancer research course of study focuses on Tumor necrosis factor alpha and Signal transduction.

His studies in T cell integrate themes in fields like Molecular biology, CD80, Immune tolerance and Cell biology. Transplantation is closely connected to T lymphocyte in his research, which is encompassed under the umbrella topic of Cytotoxic T cell. His Antigen research integrates issues from Tumor microenvironment, B7-H1 Antigen and Clonal anergy.

He most often published in these fields:

  • Immunology (55.21%)
  • Cancer research (36.98%)
  • Immune system (30.21%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (36.98%)
  • Antigen (20.83%)
  • Antibody (10.42%)

In recent papers he was focusing on the following fields of study:

Koji Tamada mostly deals with Cancer research, Antigen, Antibody, Immune system and Cancer immunotherapy. His research in Cancer research intersects with topics in Chemokine, Chimeric antigen receptor, Immunotherapy and Cell therapy. He specializes in Antigen, namely Peptide vaccine.

T cell and CD8 are the core of his Immune system study. His T cell research includes elements of Cytotoxic T cell and Dendritic cell. Koji Tamada has researched Cancer immunotherapy in several fields, including Vector, Blockade, Clinical trial and Virology.

Between 2018 and 2021, his most popular works were:

  • Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment (19 citations)
  • Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells. (13 citations)
  • Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells. (12 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

The scientist’s investigation covers issues in Cancer research, Chimeric antigen receptor, Immunotherapy, Antigen and Tumor microenvironment. His studies deal with areas such as Immunohistochemistry, Peptide vaccine, Human leukocyte antigen, XCL1 and Programmed cell death as well as Cancer research. His Human leukocyte antigen study integrates concerns from other disciplines, such as Glypican 3, Immune system, Poly ICLC, Antibody and TIGIT.

He is involved in the study of Immune system that focuses on T cell in particular. His biological study spans a wide range of topics, including Induced pluripotent stem cell, Innate lymphoid cell, Interferon gamma and Cancer immunotherapy. His Tumor microenvironment study combines topics in areas such as Haematopoiesis, Ligand, Downregulation and upregulation, Immunity and PD-L1.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Haidong Dong;Scott E. Strome;Diva R. Salomao;Hideto Tamura.
Nature Medicine (2002)

4282 Citations

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Haidong Dong;Gefeng Zhu;Koji Tamada;Lieping Chen.
Nature Medicine (1999)

2391 Citations

Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity

Fumiya Hirano;Katsumi Kaneko;Hideto Tamura;Haidong Dong.
Cancer Research (2005)

1073 Citations

B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

Andrei I. Chapoval;Jian Ni;Julie S. Lau;Ryan A. Wilcox.
Nature Immunology (2001)

961 Citations

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

Gabriel L. Sica;In Hak Choi;In Hak Choi;Gefeng Zhu;Koji Tamada.
Immunity (2003)

856 Citations

B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma

Scott E. Strome;Haidong Dong;Hideto Tamura;Stephen G. Voss.
Cancer Research (2003)

582 Citations

LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response

Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Yifan Zhai.
Journal of Immunology (2000)

435 Citations

B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes

Haidong Dong;Gefeng Zhu;Koji Tamada;Dallas B. Flies.
Immunity (2004)

432 Citations

Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS

Shengdian Wang;Gefeng Zhu;Andrei I. Chapoval;Haidong Dong.
Blood (2000)

376 Citations

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Koji Tamada;Koji Shimozaki;Andrei I. Chapoval;Gefeng Zhu.
Nature Medicine (2000)

360 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Koji Tamada

Lieping Chen

Lieping Chen

Yale University

Publications: 207

Gordon J. Freeman

Gordon J. Freeman

Harvard University

Publications: 100

Arlene H. Sharpe

Arlene H. Sharpe

Harvard University

Publications: 82

Haidong Dong

Haidong Dong

Mayo Clinic

Publications: 79

Yang-Xin Fu

Yang-Xin Fu

The University of Texas Southwestern Medical Center

Publications: 79

Byoung S. Kwon

Byoung S. Kwon

Tulane University

Publications: 72

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 70

Miyuki Azuma

Miyuki Azuma

Tokyo Medical and Dental University

Publications: 64

Xueguang Zhang

Xueguang Zhang

Soochow University

Publications: 59

Ignacio Melero

Ignacio Melero

University of Navarra

Publications: 58

Carl F. Ware

Carl F. Ware

Discovery Institute

Publications: 49

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 47

Charles G. Drake

Charles G. Drake

Columbia University

Publications: 41

James P. Allison

James P. Allison

The University of Texas MD Anderson Cancer Center

Publications: 40

André Nussenzweig

André Nussenzweig

National Institutes of Health

Publications: 37

Tasuku Honjo

Tasuku Honjo

Kyoto University

Publications: 34

Something went wrong. Please try again later.